137 related articles for article (PubMed ID: 7929084)
21. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment.
McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z
J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489
[TBL] [Abstract][Full Text] [Related]
23. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
Edelstein C; Mandala M; Pfaffinger D; Scanu AM
Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
[TBL] [Abstract][Full Text] [Related]
24. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
Edelstein C; Italia JA; Scanu AM
J Biol Chem; 1997 Apr; 272(17):11079-87. PubMed ID: 9111002
[TBL] [Abstract][Full Text] [Related]
25. Identification of the proteoglycan binding site in apolipoprotein B48.
Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
[TBL] [Abstract][Full Text] [Related]
26. The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.
Trieu VN; Olsson U; McConathy WJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):17-22. PubMed ID: 7717972
[TBL] [Abstract][Full Text] [Related]
27. Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly.
Sharp RJ; Perugini MA; Marcovina SM; McCormick SP
J Lipid Res; 2004 Dec; 45(12):2227-34. PubMed ID: 15375179
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform.
Guo HC; Michel JB; Blouquit Y; Chapman MJ
Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630
[TBL] [Abstract][Full Text] [Related]
29. The binding of animal low-density lipoproteins to human apolipoprotein(a).
Trieu VN; McConathy WJ
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
[TBL] [Abstract][Full Text] [Related]
30. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
31. The effect of individual amino acids on ApoB100 and Lp(a) secretion by HepG2 cells.
Cianflone K; Zhang Z; Vu H; Kohen-Avramoglu R; Kalant D; Sniderman AD
J Biol Chem; 1996 Nov; 271(46):29136-45. PubMed ID: 8910570
[TBL] [Abstract][Full Text] [Related]
32. Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a).
Bonen DK; Hausman AM; Hadjiagapiou C; Skarosi SF; Davidson NO
J Biol Chem; 1997 Feb; 272(9):5659-67. PubMed ID: 9038176
[TBL] [Abstract][Full Text] [Related]
33. Endothelium-dependent vasorelaxation in the aorta of transgenic mice expressing human apolipoprotein(a) or lipoprotein(a).
Rubanyi GM; Freay AD; Lawn RM
Endothelium; 2000; 7(4):253-64. PubMed ID: 11201523
[TBL] [Abstract][Full Text] [Related]
34. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
[TBL] [Abstract][Full Text] [Related]
36. Degradation of human apolipoprotein B-100 by apolipoprotein(a).
Chulkova TM; Tertov VV
FEBS Lett; 1993 Dec; 336(2):327-9. PubMed ID: 8262255
[TBL] [Abstract][Full Text] [Related]
37. Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a).
Gabel BR; McLeod RS; Yao Z; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1738-44. PubMed ID: 9812912
[TBL] [Abstract][Full Text] [Related]
38. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9.
Chung FZ; Wu LH; Lee HT; Mueller WT; Spahr MA; Eaton SR; Tian Y; Settimi PD; Oxender DL; Ramharack R
Protein Expr Purif; 1998 Jul; 13(2):222-8. PubMed ID: 9675066
[TBL] [Abstract][Full Text] [Related]
39. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].
Guevara J; Spurlino J; Jan AY; Yang CY; Tulinsky A; Prasad BV; Gaubatz JW; Morrisett JD
Biophys J; 1993 Mar; 64(3):686-700. PubMed ID: 8386013
[TBL] [Abstract][Full Text] [Related]
40. Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice.
Frank S; Hrzenjak A; Kostner K; Sattler W; Kostner GM
Biochim Biophys Acta; 1999 Apr; 1438(1):99-110. PubMed ID: 10216284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
